SYRE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Spyre Therapeutics (SYRE) Earnings Date & Reports

Industry: @Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

SYRE is expected to report earnings to fall 44.18% to -75 cents per share on February 27

Spyre Therapeutics SYRE Stock Earnings Reports

Q4'24

Est.

$-0.76

Q3'24

Missed

by $0.54

Q2'24

Beat

by $0.09

Q1'24

Missed

by $0.15

Q3'23

Missed

by $8.49

The last earnings report on November 07 showed earnings per share of -136 cents, missing the estimate of -81 cents. With 71.97K shares outstanding, the current market capitalization sits at 1.61B.

View a ticker or compare two or three

Compare

SYRE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SYRE
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for SYRE (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

221 Crescent Street

Phone

+1 617 651-5940

Employees

Web

https://www.spyre.com